Alfavision Overseas (India) Limited (ALFAVIO.BO)
INR 12.51
(-0.56%)
INR 12.51
(-0.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.78 Billion INR | -12.83% |
| 2022 | 2.04 Billion INR | -35.36% |
| 2021 | 3.16 Billion INR | 174.5% |
| 2020 | 1.15 Billion INR | 14.11% |
| 2019 | 1.01 Billion INR | 64.37% |
| 2018 | 615.44 Million INR | 41.23% |
| 2017 | 435.77 Million INR | 0.22% |
| 2016 | 434.83 Million INR | 115.54% |
| 2015 | 201.74 Million INR | -11.36% |
| 2014 | 227.6 Million INR | 47.51% |
| 2013 | 154.29 Million INR | 44.67% |
| 2012 | 106.64 Million INR | 3.62% |
| 2011 | 102.92 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.69 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.78 Billion INR | 0.0% |
| 2023 FY | 1.78 Billion INR | -12.83% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 2.04 Billion INR | -35.36% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 2.04 Billion INR | 0.0% |
| 2022 Q2 | 2.61 Billion INR | 0.0% |
| 2021 Q2 | 1.32 Billion INR | 0.0% |
| 2021 FY | 3.16 Billion INR | 174.5% |
| 2021 Q4 | 3.16 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 1.09 Billion INR | 0.0% |
| 2020 FY | 1.15 Billion INR | 14.11% |
| 2020 Q4 | 1.15 Billion INR | 0.0% |
| 2019 Q2 | 734.01 Million INR | 0.0% |
| 2019 FY | 1.01 Billion INR | 64.37% |
| 2019 Q4 | 1.01 Billion INR | 0.0% |
| 2018 Q4 | 615.44 Million INR | 0.0% |
| 2018 Q2 | 471.3 Million INR | 0.0% |
| 2018 FY | 615.44 Million INR | 41.23% |
| 2017 Q3 | 752.25 Million INR | 137.93% |
| 2017 Q2 | 316.17 Million INR | 12.64% |
| 2017 Q1 | 280.68 Million INR | -35.3% |
| 2017 FY | 435.77 Million INR | 0.22% |
| 2017 Q4 | 435.77 Million INR | -42.07% |
| 2016 FY | 434.83 Million INR | 115.54% |
| 2016 Q4 | 433.83 Million INR | 131.87% |
| 2016 Q3 | 187.1 Million INR | 12.19% |
| 2016 Q2 | 166.77 Million INR | -18.3% |
| 2016 Q1 | 204.13 Million INR | 1.18% |
| 2015 Q2 | 442.5 Million INR | 118.98% |
| 2015 FY | 201.74 Million INR | -11.36% |
| 2015 Q1 | 202.07 Million INR | -11.22% |
| 2015 Q4 | 201.74 Million INR | -51.9% |
| 2015 Q3 | 419.47 Million INR | -5.2% |
| 2014 Q1 | 154.95 Million INR | 0.43% |
| 2014 FY | 227.6 Million INR | 47.51% |
| 2014 Q4 | 227.6 Million INR | -5.76% |
| 2014 Q3 | 241.51 Million INR | 22.98% |
| 2014 Q2 | 196.39 Million INR | 26.74% |
| 2013 Q3 | 225.11 Million INR | 55.59% |
| 2013 Q4 | 154.29 Million INR | -31.46% |
| 2013 Q1 | 130.65 Million INR | 22.51% |
| 2013 FY | 154.29 Million INR | 44.67% |
| 2013 Q2 | 144.68 Million INR | 10.74% |
| 2012 FY | 106.64 Million INR | 3.62% |
| 2012 Q4 | 106.64 Million INR | -26.54% |
| 2012 Q3 | 145.17 Million INR | 0.0% |
| 2011 FY | 102.92 Million INR | 0.0% |
| 2011 Q4 | 92.45 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Biocon Limited | 560.7 Billion INR | 99.682% |
| Blue Jet Healthcare Limited | 10.58 Billion INR | 83.136% |
| Concord Biotech Limited | 17 Billion INR | 89.501% |
| Dishman Carbogen Amcis Limited | 95.81 Billion INR | 98.136% |
| FERMENTA BIOTECH LIMITED | 5.47 Billion INR | 67.406% |
| GENOMIC VALLEY BIOTECH LIMITED | 43.33 Million INR | -4020.325% |
| Lyka Labs Limited | 1.56 Billion INR | -13.933% |
| Panacea Biotec Limited | 12.4 Billion INR | 85.608% |
| SAMSRITA LABS LIMITED | 155.51 Million INR | -1048.209% |
| Servoteach Industries Limited | 1591.00 INR | -112232081.018% |
| SMS Lifesciences India Limited | 3.9 Billion INR | 54.276% |
| Supriya Lifescience Limited | 9.21 Billion INR | 80.617% |
| Syngene International Limited | 61.51 Billion INR | 97.097% |
| TAKE Solutions Limited | 881.05 Million INR | -102.669% |
| Titan Biotech Limited | 1.56 Billion INR | -14.039% |
| Transgene Biotek Limited | 324.4 Million INR | -450.431% |
| Vanta Bioscience Limited | 853.96 Million INR | -109.097% |